NanoViricides, Inc. ( NNVC) - Key Metrics
NNVC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.09 | -$0.09 | -$0.09 |
| 2026Q2 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2026Q1 | $0 | -$0.10 | -$0.09 | -$0.10 |
| 2025Q4 | $0 | -$0.13 | -$0.10 | -$0.10 |
| 2025Q3 | $0 | -$0.14 | -$0.12 | -$0.12 |
NNVC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -2.48 |
| 2026Q2 | 0% | -2.57 |
| 2026Q1 | 0% | -3.57 |
| 2025Q4 | 0% | -2.69 |
| 2025Q3 | 0% | -2.09 |
NNVC
Price: $1.05
52 week price:
Earnings Per Share: -0.44 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10400
Market Capitalization: 28.6 million